ME02407B - Soli i solvati derivata tetrahidroizohinolina - Google Patents
Soli i solvati derivata tetrahidroizohinolinaInfo
- Publication number
- ME02407B ME02407B MEP-2016-98A MEP9816A ME02407B ME 02407 B ME02407 B ME 02407B ME P9816 A MEP9816 A ME P9816A ME 02407 B ME02407 B ME 02407B
- Authority
- ME
- Montenegro
- Prior art keywords
- solvates
- salt
- tetrahydroisoquinoline derivative
- tetrahydroisoquinoline
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36636710P | 2010-07-21 | 2010-07-21 | |
| EP11740973.0A EP2595960B1 (en) | 2010-07-21 | 2011-07-21 | Salt and solvates of a tetrahydroisoquinoline derivative |
| PCT/GB2011/001096 WO2012010843A1 (en) | 2010-07-21 | 2011-07-21 | Salt and solvates of a tetrahydroisoquinoline derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME02407B true ME02407B (me) | 2016-09-20 |
Family
ID=44386640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2016-98A ME02407B (me) | 2010-07-21 | 2011-07-21 | Soli i solvati derivata tetrahidroizohinolina |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US8614227B2 (me) |
| EP (2) | EP2595960B1 (me) |
| JP (3) | JP5948326B2 (me) |
| CN (2) | CN103003244B (me) |
| AU (3) | AU2011281381B2 (me) |
| CA (1) | CA2803699C (me) |
| DK (1) | DK2595960T3 (me) |
| ES (1) | ES2570135T3 (me) |
| HK (1) | HK1224290A1 (me) |
| HR (1) | HRP20160540T1 (me) |
| HU (1) | HUE028620T2 (me) |
| ME (1) | ME02407B (me) |
| NZ (2) | NZ605444A (me) |
| PL (1) | PL2595960T3 (me) |
| PT (1) | PT2595960E (me) |
| SI (1) | SI2595960T1 (me) |
| SM (1) | SMT201600171B (me) |
| WO (1) | WO2012010843A1 (me) |
| ZA (1) | ZA201300169B (me) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2595960T3 (en) * | 2010-07-21 | 2016-05-09 | Novartis Ag | Salt and solvates of a tetrahydroisoquinoline derivative |
| US9320530B2 (en) * | 2013-03-13 | 2016-04-26 | The Spectranetics Corporation | Assisted cutting balloon |
| EP3019477B1 (en) * | 2013-07-08 | 2021-05-26 | Novartis AG | Heterocyclic compounds and methods of their use |
| JP6667551B2 (ja) | 2015-01-13 | 2020-03-18 | ノバルティス アーゲー | アンジオテンシンｉｉ２型拮抗薬としてのピロリジン誘導体 |
| US10308628B2 (en) | 2015-03-12 | 2019-06-04 | Novartis Ag | Heterocyclic compounds and methods for their use |
| CN106478502B (zh) * | 2015-08-29 | 2021-04-27 | 上海翰森生物医药科技有限公司 | 1,2,3,4-四氢异喹啉衍生物、其制备方法和应用 |
| US20190152918A1 (en) | 2016-06-27 | 2019-05-23 | Ratiopharm Gmbh | Crystalline calcium salt of (s)-2-(diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid |
| WO2018172950A1 (en) | 2017-03-23 | 2018-09-27 | Novartis Ag | Anhydrous crystalline forms of sodium (s)-2-(diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinolinecarboxylate |
| KR102132761B1 (ko) | 2017-06-09 | 2020-07-17 | 산동 단홍 파머수티컬 컴퍼니., 리미티드. | At2r 수용체 길항제로서의 카르복시산 유도체 |
| WO2020012266A1 (en) | 2018-07-12 | 2020-01-16 | Novartis Ag | Biocatalytic synthesis of olodanrigan (ema401) from 3-(2-(benzyloxy)-3-methoxyphenyl)propenoic acid with phenylalanine ammonia lyase |
| SG11202012198QA (en) | 2018-07-12 | 2021-01-28 | Codexis Inc | Engineered phenylalanine ammonia lyase polypeptides |
| CN111620816B (zh) * | 2020-05-27 | 2023-06-02 | 上海赛默罗生物科技有限公司 | 螺桨烷类衍生物、其制备方法、药物组合物和用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5246943A (en) * | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
| US5236934A (en) | 1992-08-26 | 1993-08-17 | E. I. Du Pont De Nemours And Company | 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders |
| AU747110B2 (en) * | 1998-02-25 | 2002-05-09 | Merck & Co., Inc. | Method for decreasing QT dispersion or inhibiting the progression of QT dispersion with an angiotensin II receptor antagonist |
| PT1830869E (pt) | 2004-12-24 | 2013-08-22 | Spinifex Pharm Pty Ltd | Método de tratamento ou profilaxia |
| CN101443001B (zh) | 2006-03-20 | 2013-11-13 | 西芬克斯医药有限公司 | 治疗或预防炎性痛的方法 |
| US9095587B2 (en) * | 2010-01-19 | 2015-08-04 | Spinifex Pharmaceuticals Pty Ltd | Methods and compositions for improved nerve conduction velocity |
| DK2595960T3 (en) * | 2010-07-21 | 2016-05-09 | Novartis Ag | Salt and solvates of a tetrahydroisoquinoline derivative |
-
2011
- 2011-07-21 DK DK11740973.0T patent/DK2595960T3/en active
- 2011-07-21 PT PT117409730T patent/PT2595960E/pt unknown
- 2011-07-21 NZ NZ605444A patent/NZ605444A/en not_active IP Right Cessation
- 2011-07-21 AU AU2011281381A patent/AU2011281381B2/en not_active Ceased
- 2011-07-21 JP JP2013520203A patent/JP5948326B2/ja not_active Expired - Fee Related
- 2011-07-21 ES ES11740973T patent/ES2570135T3/es active Active
- 2011-07-21 US US13/187,882 patent/US8614227B2/en not_active Expired - Fee Related
- 2011-07-21 HU HUE11740973A patent/HUE028620T2/en unknown
- 2011-07-21 CN CN201180035468.9A patent/CN103003244B/zh not_active Expired - Fee Related
- 2011-07-21 CN CN201610152658.3A patent/CN105777636A/zh active Pending
- 2011-07-21 SI SI201130804A patent/SI2595960T1/sl unknown
- 2011-07-21 CA CA2803699A patent/CA2803699C/en not_active Expired - Fee Related
- 2011-07-21 NZ NZ708529A patent/NZ708529A/en not_active IP Right Cessation
- 2011-07-21 EP EP11740973.0A patent/EP2595960B1/en active Active
- 2011-07-21 ME MEP-2016-98A patent/ME02407B/me unknown
- 2011-07-21 PL PL11740973.0T patent/PL2595960T3/pl unknown
- 2011-07-21 WO PCT/GB2011/001096 patent/WO2012010843A1/en active Application Filing
- 2011-07-21 EP EP15200360.4A patent/EP3081557A1/en not_active Withdrawn
-
2013
- 2013-01-08 ZA ZA2013/00169A patent/ZA201300169B/en unknown
- 2013-07-03 HK HK16112556.3A patent/HK1224290A1/zh unknown
- 2013-11-18 US US14/083,391 patent/US8927575B2/en not_active Expired - Fee Related
-
2014
- 2014-12-17 US US14/573,774 patent/US9162985B2/en not_active Expired - Fee Related
-
2015
- 2015-10-06 AU AU2015238774A patent/AU2015238774A1/en not_active Abandoned
-
2016
- 2016-04-11 JP JP2016078656A patent/JP2016164178A/ja active Pending
- 2016-05-20 HR HRP20160540TT patent/HRP20160540T1/hr unknown
- 2016-06-15 SM SM201600171T patent/SMT201600171B/it unknown
-
2017
- 2017-05-15 AU AU2017203236A patent/AU2017203236A1/en not_active Abandoned
- 2017-08-14 JP JP2017156436A patent/JP2017214415A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1243417A1 (zh) | 吡啶酮和氮雜吡啶酮化合物及使用方法 | |
| HK1224290A1 (zh) | 四氫異喹啉衍生物的鹽類和溶劑化物 | |
| IL237581B (en) | Derivatives of 6-oxo-pyrazinopyrrolopyrimidines | |
| HK1178149A1 (en) | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use -4--- | |
| PL3023360T3 (pl) | Kapsułka porcjowa i zastosowanie kapsułki porcjowej | |
| IL220939A0 (en) | Compounds and methods | |
| EP2523664A4 (en) | COMPOUNDS AND METHODS | |
| HK1183014A1 (en) | Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide 6--3--2- | |
| HK1183015A1 (en) | Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide 6--3--2- | |
| EP2536283A4 (en) | PHENYLHETEROARYL DERIVATIVES AND USE METHOD THEREFOR | |
| AP3917A (en) | Subsea anchor | |
| IL220812A0 (en) | Compounds and methods | |
| EP2523560A4 (en) | CONNECTIONS AND METHODS | |
| EP2594554A4 (en) | BIARYLAMID DERIVATIVES BZW. PHARMACEUTICALLY PERMITTED SALT FROM THIS | |
| ZA201209666B (en) | Salts and polymorhs of dexrabeprazole | |
| GB201006680D0 (en) | Alarm | |
| PT2552910E (pt) | Novo polimorfo | |
| ZA201400248B (en) | Synthesis of cleistainthin a and derivatives thereof | |
| EP2586772A4 (en) | ISOQUINOLINE DERIVATIVE | |
| GB201004450D0 (en) | Compounds and methods relating thereto | |
| IL225708A0 (en) | Methods for the synthesis of scylitol and related compounds | |
| HU1000688D0 (en) | Use of trifluoro-phal | |
| TWM389317U (en) | Personal effects alarm |